Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Todd Neale

February 13, 2025

Presentation THT 2025

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 1

Presenter: Harry Rowland

February 13, 2025

Presentation THT 2025

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2

Presenter: Kartik Sundareswaran

February 13, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

Presentation THT 2025

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 12, 2025

Presentation THT 2025

Proactive Medical Management: GDMT & Diuretic Strategies Based on PA Pressure, Vital Signs, and Symptoms

Presenter: Michael Kiernan

February 12, 2025

Presentation THT 2025

Rationale for Mineralocorticoid Receptor Blockade with Finerenone in HF

Presenter: Carolyn Lam

February 12, 2025

Presentation THT 2025

The HF Physician's Approach: GDMT - Give the Darn Medicines a Try!

Presenter: Ryan Tedford

February 12, 2025

Presentation THT 2025

Impact of SGLT2 Inhibitors on Mortality and Cardiovascular Admissions in Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 12, 2025

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

PH-HFpEF: Levosimendan

Presenter: Sanjiv J. Shah

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT 2024

A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery

Presenter: Elena M. Donald

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

News Conference News THT 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

Todd Neale

March 23, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

Advertisement

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 1

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Proactive Medical Management: GDMT & Diuretic Strategies Based on PA Pressure, Vital Signs, and Symptoms

Rationale for Mineralocorticoid Receptor Blockade with Finerenone in HF

The HF Physician's Approach: GDMT - Give the Darn Medicines a Try!

Impact of SGLT2 Inhibitors on Mortality and Cardiovascular Admissions in Heart Failure With Reduced Ejection Fraction (HFrEF)

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

PH-HFpEF: Levosimendan

Debating the Role of T-TEER in the Sickest Patients

A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content